Clin Colon Rectal Surg 2018; 31(05): 301-308
DOI: 10.1055/s-0038-1642054
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Small Bowel and Colorectal Carcinoids

Raphael M. Byrne
1  Division of General and Gastrointestinal Surgery, Department of Surgery, Oregon Health & Science University, Portland, Oregon
,
Rodney F. Pommier
2  Division of Surgical Oncology, Department of Surgery, Oregon Health & Science University, Portland, Oregon
› Author Affiliations
Further Information

Publication History

Publication Date:
04 September 2018 (online)

Abstract

Neuroendocrine tumors, or carcinoid tumors, of both the midgut and hindgut are quite rare, but their incidence is increasing. Surgery is the treatment of choice in patients who can tolerate an operation and have operable disease. Options for the treatment of metastatic disease include cytoreductive surgery, somatostatin analogues, interferon α, local liver therapies (hepatic arterial embolization, ablation), chemotherapy, Peptide-Receptor Radionucleotide Radiotherapy, angiogenesis inhibitors, and mammalian target of rapamycin inhibitors.